Phase IIb clinical trials

Related by string. Phase IIb Clinical Trial * phase . phases . Phases : Phase III clinical trials . Phase III trials . Phase 2b clinical / IIB . IIBS : Phase IIb clinical . Phase IIb trial . initiate Phase IIb / clinicals . CLINICAL . Clinicals : placebo controlled clinical trials . Phase III clinical . Clinical Excellence NICE / trialed . trialing : Week Premium Trial . randomized controlled trial * *

Related by context. All words. (Click for frequent words.) 76 midstage trials 76 Phase #b/#a 75 phase IIb trial 75 Phase IIa trials 75 multicenter Phase II 75 Phase 2b clinical trials 75 phase IIb clinical 74 Factor VIIa 74 forodesine 73 Phase Ib study 73 PDE4 inhibitor 73 phase IIa clinical 73 Phase #b/#a clinical 73 phase IIb 73 Phase IIb trials 73 cannabinor 72 targeted radiotherapeutic 72 OvaRex ® MAb 72 antibody MAb 72 Allovectin 7 72 BrachySil TM 72 phase IIa 72 NP2 Enkephalin 72 midstage clinical trials 72 SinuNase ™ 72 OvaRex R 72 Personalized Immunotherapy 72 Phase 2a clinical trials 72 CRMD# 72 Panzem R NCD 72 Phase IIIb clinical 71 Fx #A 71 SinuNase TM 71 Phase Ib clinical 71 Squalamine 71 tolevamer 71 phase IIb study 71 Kamada AAT 71 FOLOTYN ® 71 MEK inhibitor 71 PSMA ADC 71 mertansine 71 JAK inhibitor 71 Archexin 71 GLP toxicology studies 71 trastuzumab DM1 T DM1 71 Spiegelmer ® 71 Phase 2a trial 71 Dacogen injection 71 CEQ# 71 ELACYT 71 reslizumab 71 Phase Ib II 71 budesonide foam 71 CB2 selective receptor agonist 71 oral ridaforolimus 71 ONCONASE R 71 Urocidin 71 Cloretazine 71 LymphoStat B TM 71 generation purine nucleoside 71 Fodosine 71 PNP inhibitor 71 eniluracil 71 RhuDex ® 71 acyclovir Lauriad R 71 TACI Ig 71 alvespimycin 71 deforolimus 70 immunotherapeutic vaccine 70 IL# PE#QQR 70 DPX Survivac 70 pharmacokinetic PK study 70 Phase 1b clinical trials 70 TRO# 70 Phase IIb III 70 tiapamil 70 PDX pralatrexate 70 Myocet 70 Dacogen decitabine 70 OvaRex 70 registrational trial 70 JZP 70 AEG# 70 Cloretazine ® 70 MAGE A3 ASCI 70 lomitapide 70 Phase Ib clinical trials 70 Phase IIB 70 Phase 2b study 70 Phase IIa trial 70 TBC# 70 huC# DM4 70 inhaled AAT 70 TLK# 70 trial evaluating PRX# 70 fosbretabulin 70 elotuzumab 70 non nucleoside inhibitor 70 PI3K/Akt pathway inhibitor 70 PF # [002] 70 HGS# 70 Mipomersen 70 dexanabinol 70 AQ4N 70 Corlux 70 Phase #b/#a trial 70 trastuzumab DM1 70 incyclinide 70 phase Ib clinical 70 Aflibercept 70 PrevOnco ™ 70 ALN PCS 70 including eniluracil ADH 70 multicenter Phase 69 Zybrestat 69 midstage clinical 69 intranasal formulation 69 IND enabling 69 BLA filing 69 Phase Ib 69 Ketotransdel 69 EGS# 69 selective androgen receptor modulator 69 Ixempra 69 Troxatyl 69 Phase 1b trial 69 GW# [003] 69 GALNS 69 HDL Selective Delipidation 69 molecular imaging radiopharmaceutical 69 glucokinase activator 69 liposomal formulation 69 IIb clinical trial 69 anticancer compound 69 Allovectin 7 R 69 Trofex 69 Proxinium TM 69 Panzem R 69 Ozarelix 69 phase 2a 69 Phase 1a clinical 69 clinical pharmacology studies 69 OncoVex 69 neratinib 69 phase Ib 69 oral prodrug 69 huN# DM1 69 Zenvia ™ 69 IV Busulfex 69 dose cohort 69 novel oral anticoagulant 69 Phase lll 69 INCB# [001] 69 PHX# 69 AERx ® 69 oral salmon calcitonin 69 RSD# oral 69 Cimzia TM 69 Nuvion 69 IMC #B 69 midstage studies 69 SUCCEED trial 69 Asentar 69 Onconase 69 TELINTRA 69 OHR/AVR# 69 Phase III trials 69 Alzhemed TM 69 AzaSite Plus 68 docetaxel Taxotere R 68 Phase #/#a 68 Phase 2b clinical 68 Phase IIIb study 68 IMA# 68 YONDELIS 68 drug GAP #B# 68 Intarcia 68 Prosaptide 68 EndoTAG TM -1 68 personalized immunotherapy 68 romidepsin novel 68 SNT MC# 68 inhaled liposomal ciprofloxacin 68 PrevOnco 68 octreotide implant 68 Plicera 68 Phase #/#a trial 68 aurora kinase 68 sterile lidocaine patch 68 RELOVAIR ™ 68 docetaxel Taxotere ® 68 ATL# [001] 68 Tanespimycin 68 Exherin TM 68 Alocrest 68 oncolytic virus therapy 68 Saforis 68 PANVAC VF 68 Tarvacin TM 68 dirucotide 68 Annamycin 68 Aurora kinase inhibitors 68 registrational 68 Cleviprex TM clevidipine 68 Immunotherapeutic 68 confirmatory Phase III 68 investigational humanized monoclonal antibody 68 isoform selective 68 Hedgehog antagonist 68 Pafuramidine 68 Omacetaxine 68 Pimavanserin 68 IRX 2 68 Tarceva TM 68 obatoclax 68 immunomodulatory therapy 68 preclinical pharmacokinetic 68 HQK 68 PTK# 68 Phase III clinical trials 68 TKM ApoB 68 Genasense ® oblimersen 68 Daclizumab 68 R#/MEM # 68 Safinamide 68 vidofludimus 68 pradefovir 68 novel therapeutic antibodies 68 bardoxolone 68 JAK2 inhibitor 68 ulimorelin 68 bicifadine 68 tezampanel NGX# 68 Degarelix 68 HuMax EGFr 68 Zenvia Phase III 68 Diamyd ® 68 Voraxaze 68 BrachySil 68 labial herpes 68 VNP#M 68 CytoFab ™ 68 cancer neuroendocrine tumor 68 Aurora kinase inhibitor 68 Phase 2a clinical 68 KNS # 68 Octreotide 68 Curaxin CBLC# 68 sodium thiosulfate STS 68 gemcitabine Gemzar ® 68 Solazed 68 GEM OS2 68 investigational antiplatelet agent 68 histamine dihydrochloride 68 Cetrorelix 68 Panzem 68 depsipeptide 68 CCR5 antagonist 68 GRN# 68 acetonide FA 68 dose escalation Phase 68 prokinetic agent 67 topically administered 67 Angiocept 67 receptor tyrosine kinase inhibitor 67 TOCOSOL 67 Viramidine 67 Aryplase 67 inhibitor RG# 67 Bicifadine 67 optimal dosing regimens 67 cathepsin K inhibitor 67 PEG SN# 67 phase IIb III 67 LUMINATE 67 vaginally administered lidocaine 67 methylnaltrexone bromide 67 lorvotuzumab mertansine 67 nalbuphine ER 67 ruxolitinib 67 thetreatment 67 Abiraterone acetate 67 CVac 67 URG# 67 GRNVAC1 67 NeuVax 67 lintuzumab SGN 67 EP #R 67 ICA # 67 OncoVEX 67 Bezielle 67 aerosolized KL4 surfactant 67 orally administered inhibitor 67 EOquin TM 67 HCD# [002] 67 sitaxsentan 67 brivaracetam 67 BCR ABL inhibitor 67 randomized Phase IIb 67 dose escalation clinical 67 CINTREDEKIN BESUDOTOX 67 hypoxia activated prodrug 67 hormone LHRH antagonist 67 tremelimumab 67 Clolar ® 67 lexidronam injection 67 Pruvel 67 CBLC# 67 treat chronic sinusitis 67 ATL# [002] 67 NV1FGF 67 pertuzumab 67 Alfimeprase 67 SinuNase 67 cysteamine bitartrate 67 vinflunine 67 Anturol TM 67 RhuDex 67 Amrubicin 67 cediranib 67 Temsirolimus 67 Azedra TM 67 Tocosol Paclitaxel 67 talactoferrin 67 oral deforolimus 67 BAY #-# 67 NPC 1C 67 Phase III clinical 67 AIMM trial 67 MGd 67 MyVax 67 Pivotal Phase III 67 nucleoside analog 67 ThermoDox R 67 seliciclib CYC# 67 Neo Bladder Augment 67 HCV protease inhibitor 67 Tykerb lapatinib 67 oral PTH 67 OncoVEX GM CSF 67 LEP ETU 67 PD LID 67 PSN# [002] 67 Phase 2b trial 67 Trofex TM 67 corticosteroid dexamethasone 67 oxymorphone ER 67 HDL Mimetic Peptide 67 ospemifene 67 Xanafide 67 BrachySil ™ 67 CytoFabTM 67 CRD5 67 RNAi therapeutic targeting 67 Vicinium TM 67 selective S#P# receptor agonist 67 Civacir 67 MEK inhibitor RDEA# 67 Allovectin 7 ® 67 histone deacetylase HDAC inhibitor 67 initiate Phase IIb 67 CRLX# 67 novel histone deacetylase 67 Onalta ™ 67 orBec 67 thalidomide Thalomid 67 liposomal ciprofloxacin 67 miconazole Lauriad ® 67 torezolid phosphate 67 MAXY alpha 67 CDP# 67 BEMA TM Fentanyl 67 Phase III randomized controlled 67 cilengitide 67 IND submission 67 Velcade bortezomib 67 investigational therapies 67 volociximab 67 severe hypercholesterolemia 67 Nexavar sorafenib 67 Onco TCS 67 HuMax CD4 67 doxorubicin Transdrug ® 67 SNS# T 67 EXPAREL ™ 67 opioid induced bowel dysfunction 67 intravenous acetaminophen 67 PRECISE trial 67 PEARL SC 67 Proellex TM 67 Zavesca R 67 IAP inhibitors 67 IAP inhibitor 67 CYT# potent vascular disrupting 67 BioNumerik 67 REOLYSIN ® 67 GSK# [002] 67 DCVax R 67 GAMMAGARD 67 Gleevec imatinib mesylate 67 Hsp# Inhibitor 67 rALLy clinical trial 67 Davanat 67 Chemophase 67 radiation sensitizer 67 GVAX ® 66 Onrigin 66 Phase 2a 66 APEX PD 66 ACV1 66 anti CD3 monoclonal 66 Nanobody 66 OMP #M# 66 Excellagen TM 66 investigational hepatitis C 66 beta 1a 66 sorafenib tablets 66 VITAL Trial 66 Afatinib 66 Androxal TM 66 Guanilib 66 Orally administered 66 alemtuzumab Campath 66 cetuximab Erbitux 66 cangrelor 66 PEGylated interferon 66 inhaled formulation 66 preclinical efficacy 66 vivo preclinical 66 IMC A# 66 Dextofisopam 66 Vidaza azacitidine 66 Urocortin 2 66 gefitinib Iressa 66 investigational oral hepatitis C 66 pain palliation 66 Phase III Clinical Trial 66 vivo toxicology 66 pivotal bioequivalence 66 Insegia 66 Glybera 66 cutaneous T 66 Vernakalant 66 cardio renal 66 PRT# 66 RezularTM 66 clevidipine 66 drug ISA# 66 Diabetic Macular Edema DME 66 DXL# 66 Evoltra ® 66 Soliris TM eculizumab 66 ADVANCE PD 66 clinical trials 66 AMD# [003] 66 Aganocide 66 MKC# MT 66 2 methoxyestradiol 66 Elvitegravir 66 Enzastaurin 66 IIa trial 66 Aplidin 66 Surfaxin LS 66 PLK1 SNALP 66 albiglutide 66 INS# [001] 66 visilizumab 66 Reverset 66 acyclovir Lauriad ® 66 Panzem ® 66 VitiGam 66 esophageal candidiasis 66 romazarit 66 teriflunomide 66 sorafenib Nexavar 66 DEB# 66 EVIZON TM 66 THR beta agonist 66 Zemiva TM 66 therapeutic monoclonal antibody 66 Novolimus 66 Prodarsan R 66 liprotamase 66 Deforolimus 66 GED aPC 66 verteporfin 66 L BLP# 66 vinorelbine tartrate 66 metastatic sarcomas 66 multi kinase inhibitor 66 Phase IIb trial 66 omacetaxine mepesuccinate 66 Cloretazine R 66 RSR# 66 Solazed TM 66 ALN TTR 66 LHRH antagonist 66 Bevasiranib 66 rifalazil 66 Hedgehog Pathway Inhibitor 66 HepeX B 66 Pyridorin 66 tramiprosate Alzhemed TM 66 CR# vcMMAE 66 Anavex #-# 66 Phase IIIb 66 Phase IIb clinical 66 RhuDex R 66 MyVax ® 66 SAR# [004] 66 enzastaurin 66 non nucleoside HCV 66 ixabepilone 66 Phase 1b clinical 66 Dyloject TM 66 Cethrin 66 investigational monoclonal antibody 66 UPLYSO 66 Phase 1b 66 class mGluR5 inhibitor 66 budiodarone 66 Lixivaptan 66 HDAC Inhibitor 66 epigenetic therapies 66 StemEx 66 rxRNA 66 BLP# Liposome Vaccine 66 nitric oxide donating prostaglandin 66 Allovectin 7 r 66 CTAP# Capsules 66 Quinamed 66 PREOS R 66 CCR5 mAb 66 Cand5 66 Cloretazine R VNP#M 66 ularitide 66 MBP# [001] 66 UVIDEM 66 EOquin 66 ILUVIEN ® 66 BLA submission 66 RhuDex TM 66 Phase 2b Clinical Trial 66 urocortin 2 66 apoptosis inducer 66 Fibrin Pad 66 Cannabinor 66 Enzyme Replacement Therapy 66 DCCR 66 PSN# [001] 66 apricitabine ATC 66 triphendiol 66 Liprostin 66 investigational pan BCR 66 ganaxolone 66 Phase III Pivotal 66 terlipressin 66 IIa trials 66 Inhalation Solution 66 indibulin 66 virus HCV protease inhibitor 66 bortezomib Velcade 66 Alferon N 66 ZACTIMA 66 Tesetaxel 66 recombinant factor VIIa 66 Vitaxin 66 ASONEP 66 ® natalizumab 66 MYDICAR 66 monoclonal antibody conjugated 66 mitogen activated ERK kinase 66 metastatic malignant 66 XmAb 66 PORxin TM 66 nucleotide analog 66 assessing T DM1 66 nonclinical studies 66 renin inhibitors 66 Xcytrin R 66 Xelox 66 velafermin 66 Phase III Clinical Trials 66 Ramoplanin 66 pediatric acute lymphoblastic 66 Omigard 66 Iluvien ® 66 confirmatory Phase 3 66 Initiate Clinical Trial 66 Pivotal Clinical Trial 66 INSPIRE Trial Phase III 66 Phase IIb 66 Cellegesic 66 LEUKINE 66 oral methylnaltrexone 66 Phase III registrational 66 Microplasmin 66 delivers fluocinolone acetonide FA 66 oral taxane 66 Ridaforolimus 65 oral antiviral 65 oxypurinol 65 Memryte 65 Phase IIa clinical trials 65 BRAF inhibitor 65 histone deacetylase inhibitor 65 Chimigen TM 65 Acute Radiation Syndrome ARS 65 zanolimumab 65 PGL# 65 AKT inhibitor 65 PEGylated interferon beta 1a 65 faropenem 65 compound INCB# 65 cetuximab Erbitux R 65 isavuconazole 65 novel VDA molecule 65 Avastin adjuvant 65 ATG Fresenius S 65 Collategene 65 Spiegelmer 65 Capesaris 65 Xcellerated T Cells 65 baminercept 65 Myelodysplastic Syndrome MDS 65 sunitinib malate 65 Dalbavancin 65 ALN HPN 65 Achieves Primary Endpoint 65 systemically administered 65 dalbavancin 65 novel peptide 65 Aerosurf 65 Panzem NCD 65 Triapine R 65 Protexia ® 65 JAK3 inhibitor 65 TOCOSOL Camptothecin 65 randomized controlled Phase 65 ZYBRESTAT TM 65 TASKi3 65 bazedoxifene 65 small molecule tyrosine 65 MKC# MKC# PP 65 recurrent metastatic 65 OncoGel 65 QLT# 65 rALLy trial 65 benign prostatic hypertrophy BPH 65 rhIGF-I/rhIGFBP-3 65 multicenter phase 65 Octreolin 65 catheter occlusion 65 EDEMA3 65 MyVax R 65 Chrysalin 65 Canvaxin 65 ZOLINZA 65 Junovan TM 65 PDE# inhibitors 65 Diamyd R 65 TASKi2 65 Neupogen ® 65 Campath ® 65 Factor Xa inhibitor 65 dextofisopam 65 Uvidem 65 Soliris eculizumab 65 EXPAREL TM 65 afamelanotide 65 Litx 65 PNT# 65 Initiates Clinical 65 ALN TTR# 65 Cotara ® 65 rindopepimut 65 Triapine 65 targeted antifolate 65 MAXY G# 65 Aviptadil 65 ENRICH trial 65 Sanvar R 65 Ceflatonin R 65 XL# XL# 65 Phase III metastatic melanoma 65 ARIKACE ™ 65 LBH# 65 tafamidis 65 TNFerade TM 65 MOZOBIL 65 rNAPc2 65 Cinquil 65 ALN VSP Phase 65 tubulin inhibitor 65 apaziquone 65 squalamine 65 vaccines oncolytic virus 65 tezampanel 65 recurrent glioblastoma multiforme 65 preclinical pharmacology 65 Iloperidone 65 Exherin 65 Phase Ib IIa 65 Phase IIa clinical 65 CHAMPION PCI 65 orally bioavailable 65 alkylating agent 65 STRIDE PD 65 oral calcitonin 65 RNA antagonists 65 iii GTx 65 Cintredekin Besudotox 65 lucinactant 65 placebo controlled clinical 65 SPRYCEL ® 65 Gattex 65 Dual Opioid 65 ganetespib 65 Nexavar ® 65 aflibercept 65 refractory chronic lymphocytic 65 dacetuzumab 65 Veronate 65 AeroLEF TM 65 subcutaneous formulation 65 Ophena TM 65 cancer immunotherapies 65 SAR# [002] 65 investigational protease inhibitor 65 axitinib 65 nephropathic cystinosis 65 Glybera R 65 lapatinib Tykerb 65 immatics 65 confirmatory clinical 65 ZEVALIN ® 65 Viprinex 65 Phase IIa 65 radiolabeled TM# 65 REGN# 65 Altastaph 65 ancrod 65 E2F Decoy 65 Proquin XR 65 brivanib 65 ocrelizumab 65 ketolide antibiotic 65 P#X# antagonist 65 Egrifta 65 vosaroxin 65 CIMZIA TM 65 Hepatocellular Carcinoma HCC 65 SCIB1 65 paclitaxel Taxol ® 65 BRIM2 65 telaprevir VX 65 synthetic retinoid 65 BEMA Granisetron 65 AMEVIVE 65 PEGPH# 65 OMP #R# 65 microtubule inhibitor 65 pouchitis 65 Selective Electrochemical Tumor Ablation 65 antimetabolite 65 TPI ASM8 65 Tovaxin TM 65 GLPG# 65 TransMID 65 lumiliximab 65 oral beclomethasone dipropionate 65 diarrhea predominant irritable 65 KRN# 65 Aloxi injection 65 PXD# 65 Arikace 65 DermaVir Patch 65 Phase IIb Clinical Trial 65 balsalazide tablet 65 EmbraceAC 65 Leukine ® 65 MyVax personalized immunotherapy 65 trastuzumab Herceptin R 65 somatostatin analogue 65 Neo Kidney Augment 65 phase IIIb 65 Camvia 65 Fibrillex TM 65 Vascugel 65 oral anticancer 65 JAK1 65 factor VIIa 65 candidate deforolimus 65 Abbokinase 65 OMNARIS HFA 65 TG# [003] 65 Traficet EN 65 MYCAMINE 65 Hyphanox 65 Pivotal Trial 65 refractory prostate cancer 65 Targeted Chemotherapy 65 p# MAP kinase inhibitor 65 Zolinza 65 phase III isavuconazole 65 ara C 65 NP2 65 ritonavir boosted danoprevir 65 PROSTASCINT R 65 Amigal 65 Elocalcitol 65 Icatibant 65 Hepatitis C HCV 65 inhalation powder 65 Xyfid TM 65 MGN# 65 novel immunotherapeutic 65 Campath alemtuzumab 65 selective modulator 65 evaluating satraplatin 65 initiate Phase 1b 65 Tovaxin ® 65 overactive bladder AA# 65 Elagolix 65 Ocrelizumab 65 Phase III multicenter 65 Initiate Phase 65 ESBA# 65 ADP receptor antagonist 65 immunological diseases 65 haematological cancers 65 SYN# 65 tanespimycin 65 orally inhaled 65 TOCOSOL Paclitaxel 65 pediatric malignancies 65 ocular formulation 65 chronic thromboembolic pulmonary 65 ThGRF 65 CD# CEA 65 humanized monoclonal 65 Trovax 65 Phase III 65 orally dosed 65 AAG geldanamycin analog 65 EndoTAG TM 65 telomerase inhibitor drug 65 riociguat 65 treatment naive genotype 65 vorinostat 65 vinca alkaloid 65 Ceplene TM 65 Bioral Amphotericin B 65 gallium nitrate 65 Glypromate 65 ProMune 64 vapreotide acetate 64 Ixabepilone 64 dextromethorphan quinidine 64 clinicaltrials 64 Cerimon 64 placebo controlled Phase 64 OVATURE 64 alvimopan 64 Specifid 64 OZURDEX ® 64 ORENCIA R 64 Sudhir Agrawal D.Phil 64 ACOMPLIA R 64 humanised monoclonal antibody 64 Pertuzumab 64 Symadex 64 Trophos 64 Vectibix panitumumab 64 gepirone ER 64 hyaluronidase enzyme 64 Bazedoxifene 64 MAA submission 64 ToGA 64 oral treprostinil 64 Azedra 64 HIV integrase inhibitor 64 Valtropin 64 Curaxin 64 Successfully Completes Phase 64 #I TM# 64 Aurexis 64 Enkephalin 64 Plenaxis TM 64 Stimuvax R 64 Ostabolin C TM 64 Proxinium 64 vascular disrupting agents 64 paclitaxel poliglumex 64 Luveniq 64 Ecallantide 64 intravesical instillation 64 Posiphen TM 64 ENTEREG ® 64 MDS AML 64 SUTENT ® 64 naronapride 64 DEEP AF 64 PREOS 64 pafuramidine 64 Oglemilast 64 IPLEX 64 Omnitarg 64 Sutent sunitinib 64 vemurafenib 64 sunitinib Sutent 64 Genasense ® 64 relapsed leukemia 64 initiated Phase Ib 64 PARP inhibitor 64 Kepivance 64 EVIZON ™ 64 Goserelin 64 long acting muscarinic 64 dirucotide MBP# 64 Bonefos 64 Insulin PH# 64 GGF2 64 compound AEOL # 64 Ophena 64 investigational HCV polymerase 64 HCV RESPOND 2 64 PEG PAL 64 Cx# [002] 64 BENLYSTA ® 64 gemcitabine Gemzar R 64 Neuvenge 64 Phase III pivotal 64 candidate XP# 64 chimeric monoclonal antibody 64 rolapitant 64 HuMax TAC 64 plasma kallikrein inhibitor 64 Phase III confirmatory 64 teduglutide 64 TRX1 64 malignant ascites 64 TRANSDUR Bupivacaine 64 mGluR5 negative 64 ghrelin antagonist 64 recurrent herpes labialis 64 Alvesco R 64 StemEx R 64 preclinically 64 vernakalant hydrochloride 64 Behcet uveitis 64 integrin inhibitor 64 CDK inhibitor 64 LB# [003] 64 PTH analogue 64 RIGScan CR 64 darinaparsin ZIO 64 MAXY VII 64 Vivecon 64 AFREZZA TM 64 DURIN TM 64 Preos 64 HyperAcute 64 Lymphoseek ® 64 candidate AQ4N 64 TH# [003] 64 Vascular Disrupting Agent 64 otelixizumab 64 gastrointestinal disorders ATI 64 Zosano 64 Phase IIb Trial 64 edifoligide 64 telomerase therapeutic 64 ApoB SNALP 64 opioid induced constipation OIC 64 renin inhibitor 64 candidates Dyloject TM 64 proteasome inhibitor 64 postoperative ileus POI 64 Arzerra ofatumumab 64 gastrointestinal stromal tumors GIST 64 Oncaspar 64 adalimumab Humira 64 Neuradiab 64 human IgG1 monoclonal 64 oral picoplatin 64 Breast Cancer Assay 64 Begins Dosing 64 AVE# 64 Cancidas 64 nucleotide analogue 64 R#/MEM 64 Ceflatonin 64 HepeX B TM 64 intravenous methylnaltrexone 64 thorough QT 64 European Sepsis Trial 64 ADAGIO study

Back to home page